Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naı̈ve healthy male volunteers under a naltrexone block
- 24 October 2003
- journal article
- clinical trial
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 72 (1) , 75-83
- https://doi.org/10.1016/s0376-8716(03)00188-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetic comparison of the buprenorphine sublingual liquid and tabletDrug and Alcohol Dependence, 1999
- Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.Psychopharmacology, 1999
- Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomesLife Sciences, 1997
- Bioavailability of Sublingual BuprenorphineThe Journal of Clinical Pharmacology, 1997
- Human Pharmacokinetics of Intravenous, Sublingual, and Buccal BuprenorphineJournal of Analytical Toxicology, 1996
- A Bioequivalence Study of Oral Controlled‐Release Morphine Using Naltrexone BlockadeThe Journal of Clinical Pharmacology, 1995
- Clinical pharmacology of buprenorphine: Ceiling effects at high dosesClinical Pharmacology & Therapeutics, 1994
- Enterohepatic Circulation of DrugsThe Journal of Clinical Pharmacology, 1989
- Radioimmunoassay of Buprenorphine with Iodine Label: Analysis of Buprenorphine and Metabolites in Human PlasmaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986
- Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis.British Journal of Clinical Pharmacology, 1982